NCT00274677 - Depression And Bipolar Disorder | Biotech Hunter

Enrollment

221

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions

Bipolar Disorder

Interventions

DRUG

Placebo

Experimental treatment arm

DRUG

lamotrigine

Experimental treatment

Trial Locations (19)

10021

GSK Investigational Site, New York

10570

GSK Investigational Site, Pleasantville

27609

GSK Investigational Site, Raleigh

28209

GSK Investigational Site, Charlotte

29201

GSK Investigational Site, Columbia

30060

GSK Investigational Site, Marietta

44122

GSK Investigational Site, Beachwood

47802

GSK Investigational Site, Terre Haute

63301

GSK Investigational Site, Saint Charles

71101

GSK Investigational Site, Shreveport

73118

GSK Investigational Site, Oklahoma City

77090

GSK Investigational Site, Houston

91506

GSK Investigational Site, Burbank

92108

GSK Investigational Site, San Diego

92354

GSK Investigational Site, Loma Linda

97401

GSK Investigational Site, Eugene

08021

GSK Investigational Site, Clementon

08540

GSK Investigational Site, Princeton

77555-0188

GSK Investigational Site, Galveston